Bioherent
PrivateLast Round
Early Funding
Jul 17, 2025
Total Funding Raised
$5.59M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Bioherent is a deep-tech company that develops next-generation in-vitro diagnostic (IVD) solutions using silicon photonics and proprietary surface chemistry for drug allergy testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioherent Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bioherent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 17, 2025 | ||||
| Seed | Feb 25, 2022 |
Key People
Founding team and executive leadership
Bioherent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CDTI Innvierte | Early Funding |
| Axon Partners Group | Early Funding |
| Center for Technological Development and Innovation | Seed |
| Bullnet Capital | Early Funding, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 2823% MoM, from 30 to 877.
- Jul 17, 2025
$2.28M raised from Bullnet Capital and Axon Partners Group.
Bioherent Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioherent's valuation, stock price, and market status.